The global diffuse large B-cell lymphoma therapeutics market is website experiencing rapid growth, fueled by a rising prevalence of the disease and advancements in treatment options. The market is characterized by a extensive landscape of players, including leading pharmaceutical companies and emerging biotech firms. Key drivers shaping the market